skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 7
Patent #:
10568888
Issue Dt:
02/25/2020
Application #:
16507219
Filing Dt:
07/10/2019
Publication #:
20190336506
Pub Dt:
11/07/2019
Inventors:
Adnan M. M. Mjalli, Dharma Rao Polisetti, Mustafa Guzel, Bapu Gaddam et al
Title:
TRICYCLIC COMPOUNDS AS MODULATORS OF TNF-ALPHA SYNTHESIS AND AS PDE4 INHIBITORS
Assignment: 1
Reel/Frame:
049889/0659Recorded: 07/29/2019Pages: 9
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
MJALLI, ADNAN M.M.
Exec Dt:
04/11/2011
GADDAM, BAPU
Exec Dt:
03/04/2011
POLISETTI, DHARMA RAO
Exec Dt:
03/04/2011
KOSTURA, MATTHEW J
Exec Dt:
03/08/2011
GUZEL, MUSTAFA
Exec Dt:
03/04/2011
Assignees:
VTV THERAPEUTICS LLC
4170 MENDENHALL OAKS PKWY
HIGH POINT, NORTH CAROLINA 27265
TRANSTECH PHARMA, INC.
4170 MENDENHALL OAKS PKWY
HIGH POINT, NORTH CAROLINA 27265
Correspondent:
SAMUEL B. ROLLINS
4170 MENDENHALL OAKS PKWY
HIGH POINT, NC 27265
Assignment: 2
Reel/Frame:
049932/0833Recorded: 08/01/2019Pages: 4
Conveyance:
CORRECTIVE ASSIGNMENT TO CORRECT THE PROPERTY NUMBER PREVIOUSLY RECORDED AT REEL: 44990 FRAME: 914. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT.
Assignor:
TRANSTECH PHARMA, INC.
Exec Dt:
04/12/2011
Assignee:
HIGH POINT PHARMACEUTICALS, LLC
4170 MENDENHALL OAKS PKWY
HIGH POINT, NORTH CAROLINA 27265
Correspondent:
SAMUEL B. ROLLINS
4170 MENDENHALL OAKS PKWY
HIGH POINT, NC 27265
Assignment: 3
Reel/Frame:
049933/0512Recorded: 08/01/2019Pages: 4
Conveyance:
CORRECTIVE ASSIGNMENT TO CORRECT THE PROPERTY NUMBER PREVIOUSLY RECORDED AT REEL: 49901 FRAME: 914. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT.
Assignor:
TRANSTECH PHARMA, INC.
Exec Dt:
04/12/2011
Assignee:
HIGH POINT PHARMACEUTICALS, LLC
4170 MENDENHALL OAKS PKWY
HIGH POINT, NORTH CAROLINA 27265
Correspondent:
SAMUEL B. ROLLINS
4170 MENDENHALL OAKS PKWY
HIGH POINT, NC 27265
Assignment: 4
Reel/Frame:
049910/0028Recorded: 07/30/2019Pages: 4
Conveyance:
CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).
Assignor:
HIGH POINT PHARMACEUTICALS, LLC
Exec Dt:
07/29/2015
Assignee:
VTVX HOLDINGS II LLC
4170 MENDENHALL OAKS PKWY
HIGH POINT, NORTH CAROLINA 27265
Correspondent:
SAMUEL B. ROLLINS
4170 MENDENHALL OAKS PKWY
HIGH POINT, NC 27265
Assignment: 5
Reel/Frame:
049902/0175Recorded: 07/30/2019Pages: 6
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
VTVX HOLDINGS II LLC
Exec Dt:
07/29/2015
Assignee:
VTV THERAPEUTICS LLC
4170 MENDENHALL OAKS PKWY
HIGH POINT, NORTH CAROLINA 27265
Correspondent:
SAMUEL B. ROLLINS
4170 MENDENHALL OAKS PKWY
HIGH POINT, NC 27265
Assignment: 6
Reel/Frame:
049933/0807Recorded: 08/01/2019Pages: 6
Conveyance:
CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICATION NUMBER 16506219 PREVIOUSLY RECORDED ON REEL 049910 FRAME 0028. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME.
Assignor:
HIGH POINT PHARMACEUTICALS, LLC
Exec Dt:
07/29/2015
Assignee:
VTVX HOLDINGS II LLC
4170 MENDENHALL OAKS PKWY
HIGH POINT, NORTH CAROLINA 27265
Correspondent:
SAMUEL B. ROLLINS
4170 MENDENHALL OAKS PKWY
HIGH POINT, NC 27265
Assignment: 7
Reel/Frame:
049934/0019Recorded: 08/01/2019Pages: 8
Conveyance:
CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICATION NUMBER 16506219 PREVIOUSLY RECORDED ON REEL 049902 FRAME 0175. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT.
Assignor:
VTVX HOLDINGS II LLC
Exec Dt:
07/29/2019
Assignee:
VTV THERAPEUTICS LLC
4170 MENDENHALL OAKS PKWY
HIGH POINT, NORTH CAROLINA 27265
Correspondent:
SAMUEL B. ROLLINS
4170 MENDENHALL OAKS PKWY
HIGH POINT, NC 27265

Search Results as of: 06/07/2024 09:41 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT